H G Birnbaum

Summary

Affiliation: Analysis Group
Country: USA

Publications

  1. ncbi The economic burden of schizophrenia in the United States in 2002
    Eric Q Wu
    Analysis Group, Inc, Boston, MA 02199, USA
    J Clin Psychiatry 66:1122-9. 2005
  2. ncbi Changes in utilization and costs for patients with rheumatoid arthritis, 1997 to 2006
    Howard G Birnbaum
    Analysis Group Inc, Boston, MA, USA
    Pharmacoeconomics 30:323-36. 2012
  3. ncbi Cost of stress urinary incontinence: a claims data analysis
    Howard G Birnbaum
    Analysis Group Inc, Boston, Massachusetts 02199, USA
    Pharmacoeconomics 22:95-105. 2004
  4. ncbi Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective
    Howard G Birnbaum
    Analysis Group, Inc, Boston, MA 02199, USA
    Clin J Pain 22:667-76. 2006
  5. ncbi Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance
    Howard G Birnbaum
    Analysis Group, Inc, Boston, Massachusetts, USA
    Depress Anxiety 27:78-89. 2010
  6. ncbi Lifetime medical costs for women: cardiovascular disease, diabetes, and stress urinary incontinence
    Howard Birnbaum
    Analysis Group, Inc, 111 Huntington Avenue, 10th Floor, Boston, MA 02199, USA
    Womens Health Issues 13:204-13. 2003
  7. ncbi Economic consequences of not recognizing bipolar disorder patients: a cross-sectional descriptive analysis
    Howard G Birnbaum
    Analysis Group, Inc, 111 Huntington Avenue, Boston, MA 02466, USA
    J Clin Psychiatry 64:1201-9. 2003
  8. ncbi Determinants of direct cost differences among US employees with major depressive disorders using antidepressants
    Howard G Birnbaum
    Analysis Group, Inc, Boston, Massachusetts, USA
    Pharmacoeconomics 27:507-17. 2009
  9. ncbi Lower respiratory tract infections: impact on the workplace
    Howard Birnbaum
    Analysis Group, Boston, Massachusetts 02199, USA
    Pharmacoeconomics 21:749-59. 2003
  10. ncbi Employer model of workplace impacts of anti-TNF therapy for rheumatoid arthritis
    Howard Birnbaum
    Analysis Group, Inc, Boston, MA 02199, USA
    J Occup Environ Med 51:1167-76. 2009

Detail Information

Publications64

  1. ncbi The economic burden of schizophrenia in the United States in 2002
    Eric Q Wu
    Analysis Group, Inc, Boston, MA 02199, USA
    J Clin Psychiatry 66:1122-9. 2005
    ..This study quantifies excess annual costs associated with schizophrenia patients in the United States in 2002 from a societal perspective...
  2. ncbi Changes in utilization and costs for patients with rheumatoid arthritis, 1997 to 2006
    Howard G Birnbaum
    Analysis Group Inc, Boston, MA, USA
    Pharmacoeconomics 30:323-36. 2012
    ..Given these advances, it is useful to assess how healthcare and work-loss costs of patients with RA have changed...
  3. ncbi Cost of stress urinary incontinence: a claims data analysis
    Howard G Birnbaum
    Analysis Group Inc, Boston, Massachusetts 02199, USA
    Pharmacoeconomics 22:95-105. 2004
    ....
  4. ncbi Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective
    Howard G Birnbaum
    Analysis Group, Inc, Boston, MA 02199, USA
    Clin J Pain 22:667-76. 2006
    ..This study estimates the costs to society of prescription opioid analgesic (RxO) abuse in the United States...
  5. ncbi Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance
    Howard G Birnbaum
    Analysis Group, Inc, Boston, Massachusetts, USA
    Depress Anxiety 27:78-89. 2010
    ..Treatment utilization/costs and work performance for persons with major depressive disorder (MDD) by severity of illness is not well documented...
  6. ncbi Lifetime medical costs for women: cardiovascular disease, diabetes, and stress urinary incontinence
    Howard Birnbaum
    Analysis Group, Inc, 111 Huntington Avenue, 10th Floor, Boston, MA 02199, USA
    Womens Health Issues 13:204-13. 2003
    ..To estimate the absolute and relative lifetime medical costs of treating women with cardiovascular disease (CVD), diabetes, or stress urinary incontinence (SUI)...
  7. ncbi Economic consequences of not recognizing bipolar disorder patients: a cross-sectional descriptive analysis
    Howard G Birnbaum
    Analysis Group, Inc, 111 Huntington Avenue, Boston, MA 02466, USA
    J Clin Psychiatry 64:1201-9. 2003
    ..This retrospective study compared treatment patterns and costs for patients with recognized and unrecognized bipolar disorder with those of depressed patients without a bipolar disorder claim...
  8. ncbi Determinants of direct cost differences among US employees with major depressive disorders using antidepressants
    Howard G Birnbaum
    Analysis Group, Inc, Boston, Massachusetts, USA
    Pharmacoeconomics 27:507-17. 2009
    ..To understand factors driving the economic burden of major depressive disorder (MDD) patients with different treatment regimens, by evaluating the relationship between medical profiles and treatment costs...
  9. ncbi Lower respiratory tract infections: impact on the workplace
    Howard Birnbaum
    Analysis Group, Boston, Massachusetts 02199, USA
    Pharmacoeconomics 21:749-59. 2003
    ....
  10. ncbi Employer model of workplace impacts of anti-TNF therapy for rheumatoid arthritis
    Howard Birnbaum
    Analysis Group, Inc, Boston, MA 02199, USA
    J Occup Environ Med 51:1167-76. 2009
    ..We developed a customizable model that allows employers to calculate workplace impacts of RA therapies in employees with RA...
  11. ncbi Assessing the relationship between compliance with antidepressant therapy and employer costs among employees in the United States
    Howard G Birnbaum
    Analysis Group, Inc, 111Huntington Avenue 10th floor, Boston, MA 02199, USA
    J Occup Environ Med 52:115-24. 2010
    ..To assess effects of antidepressant treatment compliance on health care and workplace costs...
  12. ncbi Societal cost of rheumatoid arthritis patients in the US
    Howard Birnbaum
    Analysis Group, Inc, Boston, MA 02199, USA
    Curr Med Res Opin 26:77-90. 2010
    ..To estimate comprehensive cost of rheumatoid arthritis (RA) patients to society and individual stakeholders, including patients/employees, employers, family members/caregivers, and government...
  13. ncbi Economic burden of pneumonia in an employed population
    H G Birnbaum
    Analysis Group Economics, One Brattle Square, Fifth Floor, Cambridge, MA 02138, USA
    Arch Intern Med 161:2725-31. 2001
    ..To estimate the overall economic burden of pneumonia from an employer perspective...
  14. ncbi Societal costs of prescription opioid abuse, dependence, and misuse in the United States
    Howard G Birnbaum
    Analysis Group, Inc, Boston, MA, USA
    Pain Med 12:657-67. 2011
    ..The objective of this study was to estimate the societal costs of prescription opioid abuse, dependence, and misuse in the United States...
  15. ncbi Prevalence rates and costs of metabolic syndrome and associated risk factors using employees' integrated laboratory data and health care claims
    Howard G Birnbaum
    Analysis Group, Inc, Boston, MA, USA
    J Occup Environ Med 53:27-33. 2011
    ..This study assessed the relative value of using laboratory, claims, or integrated laboratory-claims data to identify prevalence rates and costs of metabolic syndrome among Chevron Texaco Corporation, San Ramon, California, employees...
  16. ncbi Economic burden of respiratory infections in an employed population
    Howard G Birnbaum
    Analysis Group Economics, Boston, MA 02199, USA
    Chest 122:603-11. 2002
    ..While respiratory infections are a leading cause of morbidity, there is little information on the costs of medically treating these conditions, or on their workplace impact...
  17. ncbi The economics of women and depression: an employer's perspective
    Howard G Birnbaum
    111 Huntington Avenue, Tenth Floor, Boston, MA 02199, USA
    J Affect Disord 74:15-22. 2003
    ..This analysis focuses on the direct and indirect cost to employers of female compared to male employees treated for depression, and their service utilization patterns...
  18. ncbi Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000
    Howard G Birnbaum
    Analysis Group, Inc, Boston, MA 02199, USA
    Curr Med Res Opin 21:195-206. 2005
    ..The objective of this study is to provide a comprehensive estimate of the cost of ADHD by consider ing the healthcare and work loss costs of persons with ADHD, as well as those costs imposed on their family members...
  19. ncbi Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the US
    J I Ivanova
    Analysis Group, Inc, New York, NY, USA
    J Med Econ 15:601-9. 2012
    ..To compare rates of severe relapse and total direct and indirect costs over a 2-year period between US-based employees with multiple sclerosis (MS) who were adherent and non-adherent to disease-modifying drugs (DMDs)...
  20. ncbi Prevalence and costs of osteoporotic patients with subsequent non-vertebral fractures in the US
    C T Pike
    Analysis Group, Inc, 111 Huntington Avenue, 10th Floor, Boston, MA 02199, USA
    Osteoporos Int 22:2611-21. 2011
    ..Many non-vertebral fracture patients incur subsequent fractures, and those who do are significantly more costly during the year after incident fracture...
  21. ncbi Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Am J Psychiatry 163:1561-8. 2006
    ..Bipolar disorder has been overlooked both because of the failure to distinguish between major depressive disorder and bipolar disorder and by the failure to evaluate the workplace costs of mania/hypomania...
  22. ncbi Impact of illness and its treatment on workplace costs: regulatory and measurement issues
    P E Greenberg
    Analysis Group/Economics, One Brattle Square, Fifth Floor, Cambridge, MA 02138, USA
    J Occup Environ Med 43:56-63. 2001
    ..This discussion highlights the possible difficulties faced by the FDA in reviewing productivity-based promotional claims. Finally, we suggest possible strategies for furthering this field of investigation...
  23. ncbi A retrospective claims database analysis to assess patterns of interstitial cystitis diagnosis
    Eric Q Wu
    Analysis Group, Inc, Boston, MA 02199, USA
    Curr Med Res Opin 22:495-500. 2006
    ..This analysis assesses the potential extent of IC misdiagnosis while considering concomitant conditions in a managed care population and identifies predictors of IC diagnosis...
  24. ncbi Retrospective claims data analysis of dosage adjustment patterns of TNF antagonists among patients with rheumatoid arthritis
    Eric Wu
    Analysis Group, Inc, Boston, MA 02199, USA
    Curr Med Res Opin 24:2229-40. 2008
    ..To describe dosing patterns for tumor necrosis factor (TNF) antagonists in patients with rheumatoid arthritis from health care provider and payer point of interest...
  25. ncbi Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach
    Eric Q Wu
    Analysis Group, Inc, Boston, MA 02199, USA
    Psychol Med 36:1535-40. 2006
    ..This study used multiple administrative claims databases to estimate the annual prevalence of diagnosed schizophrenia in the USA...
  26. ncbi Cost of care for patients with rheumatoid arthritis receiving TNF-antagonist therapy using claims data
    Eric Wu
    Analysis Group, Inc, Boston, MA 02199, USA
    Curr Med Res Opin 23:1749-59. 2007
    ..To compare the cost of care for rheumatoid arthritis (RA) patients treated with adalimumab, infliximab, and etanercept...
  27. ncbi Workplace impacts of anti-TNF therapies in rheumatoid arthritis: review of the literature
    Howard Birnbaum
    Analysis Group, 111 Huntington Avenue, 10th Floor, MA 02199, Boston, USA
    Expert Opin Pharmacother 10:255-69. 2009
    ..Rheumatoid arthritis (RA) causes pain and serious functional impacts and substantially affects patients' daily lives, including their ability to work...
  28. ncbi Economic implications of treatment-resistant depression among employees
    Paul Greenberg
    Analysis Group Inc, Boston, Massachusetts 02199, USA
    Pharmacoeconomics 22:363-73. 2004
    ..Given the prevalence of the disorder, it is understandable that MDDs are responsible for a significant amount of both direct and indirect healthcare costs...
  29. ncbi Employees with overactive bladder: work loss burden
    Eric Q Wu
    Analysis Group, Inc, Boston, Massachusetts, USA
    J Occup Environ Med 47:439-46. 2005
    ..This study assessed the indirect work loss costs to employers as the result of employees with overactive bladder (OAB)...
  30. ncbi Interstitial Cystitis: Cost, treatment and co-morbidities in an employed population
    Eric Q Wu
    Analysis Group Inc, Boston, Massachusetts, USA
    Pharmacoeconomics 24:55-65. 2006
    ..This study assesses the direct medical cost and indirect cost of work loss for IC patients in the first year after diagnosis, and evaluates IC treatment patterns and prevalence of co-morbidities...
  31. ncbi Direct costs and survival of medicare beneficiaries with early and advanced Parkinson's disease
    A Kaltenboeck
    Analysis Group, Inc, NY 10020, USA
    Parkinsonism Relat Disord 18:321-6. 2012
    ..No recent analysis details Parkinson's Disease (PD) costs or survival for Medicare beneficiaries. This study assesses excess direct costs and survival in Medicare beneficiaries with early and advanced PD...
  32. ncbi Asthma severity categorization using a claims-based algorithm or pulmonary function testing
    H G Birnbaum
    Analysis Group, Inc, Boston, Massachusetts, USA
    J Asthma 46:67-72. 2009
    ..This study was performed to determine whether pulmonary function test results would appreciably alter asthma severity categorization determined by an algorithm using information readily available in administrative databases...
  33. ncbi Antidepressant treatment patterns and costs among US employees
    Howard Birnbaum
    Analysis Group, Inc, Boston, MA 02199, USA
    J Med Econ 12:36-45. 2009
    ..To compare medical and cost profiles of patients treated for depression classified by treatment pattern groups...
  34. ncbi Economic burden of privately insured non-vertebral fracture patients with osteoporosis over a 2-year period in the US
    C Pike
    Analysis Group, Inc, 111 Huntington Avenue, 10th Floor, Boston, MA 02199, USA
    Osteoporos Int 22:47-56. 2011
    ..Since fracture patients remained more costly in the second year, their economic burden extends beyond the year in which the fracture occurs...
  35. ncbi Assessing the economic impact of psychiatric disorders: where to begin?
    P E Greenberg
    Analysis Group Economics, One Brattle Square, Fifth Floor, Cambridge, MA 02138, USA
    Expert Opin Pharmacother 2:641-52. 2001
    ..These categories present a starting point for analysing the pharmacoeconomic consequences of psychiatric disorders and underlie an expert opinion in this context..
  36. ncbi The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Occup Environ Med 47:565-72. 2005
    ..The prevalence and workplace consequences of adult attention deficit/hyperactivity disorder (ADHD) are unknown...
  37. ncbi The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R)
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02115, USA
    Biol Psychiatry 58:668-76. 2005
    ..To estimate the prevalence and correlates of clinician-diagnosed DSM-IV nonaffective psychosis (NAP) in a national household survey...
  38. ncbi Comparative and interactive effects of depression relative to other health problems on work performance in the workforce of a large employer
    Ronald Kessler
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02115, USA
    J Occup Environ Med 50:809-16. 2008
    ..To present data on the comparative and interactive workplace costs of depression relative to other health problems in the workforce of a large employer...
  39. ncbi The economic burden of depression in the United States: how did it change between 1990 and 2000?
    Paul E Greenberg
    Analysis Group, Inc, Boston, MA 02199, USA
    J Clin Psychiatry 64:1465-75. 2003
    ..9 billion dollars using revised prevalence data and a refined workplace cost estimation approach. The objective of the current report is to provide a 10-year update of these estimates using the same methodological framework...
  40. ncbi Economic cost and epidemiological characteristics of patients with fibromyalgia claims
    Rebecca L Robinson
    Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    J Rheumatol 30:1318-25. 2003
    ..We investigated the total costs of FM in an employer population...
  41. ncbi Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population
    Alicia C Sasser
    Analysis Group, Inc, Boston, Massachusetts, USA
    Womens Health Issues 15:97-108. 2005
    ..These diseases can result in significant direct (medical treatment) and indirect (workplace) costs. The objective of this study is to assess these costs among an employed population...
  42. ncbi Attention-deficit/hyperactivity disorder: increased costs for patients and their families
    Andrine R Swensen
    Eli Lilly and Company, Indianapolis, USA
    J Am Acad Child Adolesc Psychiatry 42:1415-23. 2003
    ..Both patient and family cost differences were significant at the 95% confidence level. CONCLUSIONS: ADHD imposes a significant financial burden regarding the cost of medical care and work loss for patients and family members...
  43. ncbi The economic burden of depression with painful symptoms
    Paul E Greenberg
    Analysis Group Economics, Inc, Boston, MA 02199, USA
    J Clin Psychiatry 64:17-23. 2003
    ..However, more research is needed to assess the comprehensive economic impact that depression with painful physical symptoms can have on society...
  44. ncbi Identification of a claims data "signature" and economic consequences for treatment-resistant depression
    Patricia K Corey-Lisle
    Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
    J Clin Psychiatry 63:717-26. 2002
    ....
  45. ncbi Direct and indirect costs of asthma to an employer
    Howard G Birnbaum
    Analysis Group/Economics, Cambridge, MA 02138, USA
    J Allergy Clin Immunol 109:264-70. 2002
    ..CONCLUSION: Failure to account fully for the broader consequences of asthma in terms of indirect and comorbid treatment costs would result in a significant underassessment of the cost of asthma to an employer...
  46. ncbi Productivity and medical costs of diabetes in a large employer population
    Scott Ramsey
    Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington, USA
    Diabetes Care 25:23-9. 2002
    ..Employers should select health plans that provide enriched benefits to diabetes patients, including ready access to medical and pharmacy services as well as aggressive diabetes management programs...
  47. ncbi The economic consequences of irritable bowel syndrome: a US employer perspective
    Stephanie A Leong
    Analysis Group Economics, Boston, MA 02199, USA
    Arch Intern Med 163:929-35. 2003
    ....
  48. ncbi Costs and resource use of mild persistent asthma patients initiated on controller therapy
    Gene L Colice
    The George Washington University School of Medicine and Washington Hospital Center, Washington, DC, USA
    J Asthma 45:293-9. 2008
    ..The treatment of mild persistent asthma is controversial...
  49. ncbi Direct and indirect costs among employees with diabetic retinopathy in the United States
    Lauren J Lee
    Eli Lilly and Company, Lilly Research Laboratories, Indianapolis, IN, USA
    Curr Med Res Opin 24:1549-59. 2008
    ..To examine, from the employer perspective, the direct (healthcare) and indirect (workloss) costs of employees with diabetic retinopathy (DR) compared to control non-DR employees with diabetes, and within DR subgroups...
  50. ncbi Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients
    Andrine Swensen
    Eli Lilly and Company, Indianapolis, Indiana, USA
    J Adolesc Health 35:346.e1-9. 2004
    ..7 times greater than for controls. CONCLUSIONS: ADHD was a significant predictor of having an accident claim. However, for people with an accident claim, ADHD patients and controls had a similar number of accident claims and costs...
  51. ncbi Direct costs of opioid abuse in an insured population in the United States
    Alan G White
    Analysis Group, Inc, 111 Huntington Ave, 10th Fl, Boston, MA 02199, USA
    J Manag Care Pharm 11:469-79. 2005
    ..g., inpatient, outpatient, emergency room, drug, other) from the perspective of a private payer...
  52. ncbi Assessing the economic impact of chronic conditions in postmenopausal women
    Alicia C Sasser
    Analysis Group, Inc, 111 Huntington Avenue, Boston, MA 02199, USA
    Expert Opin Pharmacother 6:1803-14. 2005
    ..Taken together, these factors are used to analyse the overall economic impact of postmenopausal disorders and to provide an expert opinion in this context...
  53. ncbi Economic burden of illness for employees with painful conditions
    Alan G White
    Analysis Group, Inc, Boston, Massachusetts, USA
    J Occup Environ Med 47:884-92. 2005
    ..We sought to compare the medical services utilization and average annual direct (ie, medical and medication) and indirect (ie, work-loss) costs for employees with painful conditions to a random sample ("average employee")...
  54. ncbi Economic burden and co-morbidities of atrial fibrillation in a privately insured population
    Eric Q Wu
    Analysis Group, Inc, Boston, MA 02119, USA
    Curr Med Res Opin 21:1693-9. 2005
    ..This study assesses the direct (medical and drugs) and indirect (work loss) annual costs associated with Atrial Fibrillation (AFIB) in a privately insured population...
  55. ncbi Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently
    Rebecca L Robinson
    Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    J Rheumatol 31:1621-9. 2004
    ..Both syndromes share common symptoms and impose significant economic burdens. This study compared claims for treatment and costs of FM plus depression with those for FM or depression alone...
  56. ncbi Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain
    Eric Q Wu
    Analysis Group, Inc, Boston, Massachusetts 02199, USA
    J Pain 7:399-407. 2006
    ..From both employer perspective and societal perspective (including patient's out-of-pocket costs), this study demonstrated that duloxetine was more cost-effective than routine treatment in management of DPNP...
  57. ncbi Treatment costs of community-acquired pneumonia in an employed population
    Gene L Colice
    Pulmonary, Critical Care and Respiratory Services, Washington Hospital Center, Washington, DC, USA
    Chest 125:2140-5. 2004
    ..Work-loss cost estimates indicate that the treatment of CAP also has a large economic impact. The purpose of this study was to assess the medical and prescription drug (treatment) costs of managing CAP in an employed population...
  58. ncbi Foundations of opioid risk management
    Nathaniel P Katz
    Tufts University School of Medicine, Boston, MA, USA
    Clin J Pain 23:103-18. 2007
    ..Limitations of current approaches, and emerging directions in opioid risk management, are also presented...
  59. ncbi Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies
    Eric Q Wu
    Analysis Group, Inc, Boston, MA 02199, USA
    J Manag Care Pharm 13:561-9. 2007
    ....
  60. ncbi Actual versus predicted first-year utilization patterns of teriparatide in patients with employer-sponsored health insurance
    Eric S Meadows
    Eli Lilly and Company, Indianapolis, IN, USA
    Curr Med Res Opin 23:3215-22. 2007
    ..To characterize first-year utilization patterns of teriparatide derived from a claims database analysis versus predictions from an economic model...
  61. ncbi Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss
    Leigh Ann White
    Analysis Group, Inc, 111 Huntington Avenue, Boston, MA 02199, USA
    J Occup Environ Med 50:13-24. 2008
    ..To compare 2005 health care resources among matched samples of employees with fibromyalgia (FM), osteoarthritis (OA), and controls...
  62. ncbi The economic burden of depression in the US: societal and patient perspectives
    Paul E Greenberg
    Analysis Group, Inc, 111 Huntington Ave, 10th Floor, Boston, MA 02199, USA
    Expert Opin Pharmacother 6:369-76. 2005
    ..Future investigation is likely to focus on the relationship between depression and comorbid conditions, the role of caregiver burdens, and the economic differences in life outcomes...
  63. ncbi Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data
    Andrew P Yu
    Analysis Group, Inc, Boston, MA 02199, USA
    Curr Med Res Opin 23:2157-69. 2007
    ..Although clinical benefits of weight loss have been established, the economic consequence of weight change among patients with type 2 diabetes is unclear...
  64. ncbi Prevalence, referral patterns, testing, and surgery in aortic valve disease: leaving women and elderly patients behind?
    David S Bach
    Department of Internal Medicine, Division of Cardiovascular Medicine, The University of Michigan, Ann Arbor, MI 48109, USA
    J Heart Valve Dis 16:362-9. 2007
    ....